Comparison of prostate cancer gene 3 score, prostate health index and percentage free prostate-specific antigen for differentiating histological inflammation from prostate cancer and other non-neoplastic alterations of the prostate at initial biopsy.
Stefano De Luca(University of Campania "Luigi Vanvitelli"), F. Porpiglia(Ospedale San Luigi Gonzaga), Enrico Bollito(Prostate Cancer UK), Antonino Sottile(Candiolo Cancer Institute), Roberto Passera(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Roberto Mario Scarpa(University of Turin), Matteo Manfredi(Ospedale San Luigi Gonzaga), Donato Randone(Ospedale Humanitas Gradenigo)
PubMed
December 1, 2014
Cited by 8
Related Papers
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
The Clinical Research Office of the Endourological Society Percutaneous Nephrolithotomy Global Study: Indications, Complications, and Outcomes in 5803 Patients
|Journal of Endourology|2011|818
A Clinical Outcome-Based Prospective Study on Venous Thromboembolism After Cancer Surgery
|Annals of Surgery|2005|688